Ryan & Maniskas, LLP Announces Investigation of MEDTOX Scientific Inc.

Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/mtox) is investigating potential claims against the board of directors of MEDTOX Scientific Inc. (“MEDTOX” or the “Company”) (NASDAQ: MTOX) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s efforts to sell MEDTOX to Laboratory Corporation of America® Holdings in a transaction valued at approximately $241 million.

Our investigation concerns possible breaches of fiduciary duty and other violations of law related to the approval of the transaction by the Company’s board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for all shareholders of MEDTOX. For more information regarding our investigation, please contact Ryan & Maniskas, LLP (Richard A. Maniskas, Esquire) toll-free at [phone] or by email at [e-mail] or visit: www.rmclasslaw.com/cases/mtox.

Under the terms of the transaction, MEDTOX shareholders will receive $27.00 for each share of MEDTOX stock they own.

If you own shares of MEDTOX and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at [phone] or to sign up online, visit: www.rmclasslaw.com/cases/mtox. You may also email Mr. Maniskas at [e-mail]. For more information about class action cases in general, please visit our website: www.rmclasslaw.com.

Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.